What is Righteye?
Founded in 2012 and headquartered in Bethesda, Maryland, RightEye, LLC leverages advanced eye-tracking technology and gamification to enhance healthcare outcomes and vision performance. The company's proprietary RightEye EyeQ tests offer healthcare providers an objective, metric-driven methodology for assessing eyesight, identifying potential brain and reading disorders, and evaluating performance issues in patients. Its cloud-based platform delivers rapid reports, enabling clinicians to objectively monitor vision quality and treatment efficacy. RightEye's solutions cater to diverse industries including sports, military, law enforcement, and health, providing specialized tools like the Scanning Precision Eyesight Capture Solution and the RightEye Reading Test for educators and specialists to detect reading disorders.
How much funding has Righteye raised?
Righteye has raised a total of $10.2M across 4 funding rounds:
Private Equity
$2.1M
Private Equity
$7.3M
Debt
$350K
Debt
$492K
Private Equity (2014): $2.1M, investors not publicly disclosed
Private Equity (2017): $7.3M, investors not publicly disclosed
Debt (2020): $350K supported by PPP
Debt (2021): $492K featuring PPP
What's next for Righteye?
With the recent influx of major strategic investment, RightEye, LLC is poised to accelerate its market penetration and technological advancements. The company's focus on objective, data-driven vision assessment and training aligns with a growing demand for personalized health solutions. Future endeavors will likely involve expanding its platform's capabilities, forging new strategic partnerships within the healthcare and performance sectors, and enhancing its reach to a broader patient and client base. This substantial backing signals confidence in RightEye's innovative approach to vision science and its potential to disrupt traditional methods of eye care and performance enhancement.
See full Righteye company page
